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The three processes necessary to form a com-
plete vascular network are vasculogenesis, an-
giogenesis, and vascular remodeling (Carmeliet, 
2003). Generally, vasculogenesis describes the 
de novo formation of vessels from vascular en-
dothelial precursor cells, which migrate to the 
location of future vessels, coalesce into cords, 
and differentiate into lumen-forming endothe-
lial cells. Formation of the first major vessels, 
such as the dorsal aorta or the cardinal veins, 
is well known to occur through embryonic 
vasculogenesis (Risau, 1997). Bone marrow– 
derived  endothelial  progenitor  cells  (EPCs; 
Asahara et al., 1997) are generally considered to 
participate in certain aggressive cancer models 
(Gao et al., 2008), but not in other cancer mod-
els or in physiological development (Purhonen 
et al., 2008). Therefore, increasing attention has 
been directed to vasculogenesis directed by 
other lineage cells.
Myelin  protein  zero  (Po)  was  originally 
identified  as  a  Schwann  cell–specific  protein 
(Lemke and Axel, 1985). Recent studies showed 
that Po-Cre is expressed by neural crest cells dur-
ing early embryogenesis (Yamauchi et al., 1999). 
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Vasculogenesis describes the process of de novo vessel formation from vascular precursor 
cells. Although formation of the first major vessels, such as the dorsal aorta and cardinal 
veins, occurs during embryonic vasculogenesis, the contribution of precursor cell populations 
to postnatal vessel development is not well understood. Here, we identified a novel population 
of postnatal vascular precursor cells in mice. These cells express the Schwann cell protein 
myelin protein zero (Po) and exhibit a CD45-CD31-VEcad-c-kit+CXCR4+ surface phenotype. 
Po+ vascular precursors (PVPs) are recruited into the growing vasculature, and comprise a 
minor population of arterial endothelial cells in adult mice. Recruitment of PVPs into growing 
vessels is mediated by CXCL12–CXCR4 signaling, and is enhanced during vascular expansion 
induced by Notch inhibition. Po-specific ablation of Flk1, a receptor for VEGF, results in 
branching defects and insufficient arterial patterning in the retina, as well as reduced neo-
vascularization of tumors and ischemic tissues. Thus, in postnatal mice, although growing 
vessels are formed primarily by angiogenesis from preexisting vessels, a minor population of 
arterial endothelia may be derived from tissue-resident vascular precursor cells.
©  2011  Kubota  et  al.  This  article  is  distributed  under  the  terms  of  an   
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org/licenses/by-nc-sa/3.0/).
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Moreover,  some  spindle-shaped  GFP+  cells  were  directly   
associated with endothelial tip cell filopodia (Fig. 1, E–G). 
Unlike pericytes, GFP+ spindle-shaped cells were negative for 
NG2 and PDGFR and were localized abluminally to the 
vascular basal lamina (Fig. S1 A). GFP+ endothelial cells were 
restricted to arteries with a ladderlike pattern in adulthood 
and were detected in endothelial lumens (Fig. 1, K–P). FACS 
analysis indicated that 4.88 ± 1.84% (n = 5) of all CD31+ cells 
were GFP+ in adult (Fig. 1 Q), and most GFP+CD31+ cells 
were VE-cadherin+Tie-2+ endothelial cells (unpublished data). 
Outside the retina, GFP was also detected in endothelial cells, 
pericytes/vSMCs, and spindle-shaped cells (Fig. 1, R–T). To 
check whether these GFP+ cells in Po-Cre+Flox-CAT-EGFP 
mice are neural crest-derived or not, we examined two lines 
of transgenic mice, Wnt1-Cre, and human tissue plasminogen 
activator (Ht-PA)-Cre. We found that pericytes, but not spin-
dle-shaped cells and endothelial cells, were marked by these 
two Cre lines (Fig. 1, U–X). A previous cell fate–mapping study 
using quail/chick chimeras (Etchevers et al., 2001) agrees 
with our finding that neural crest cells give rise to peri-
cytes, but not to endothelial cells. Collectively, Po-Cre, but 
not Wnt1-Cre and Ht-PA-Cre, marked endothelial cells and 
spindle-shaped cells in avascular areas.
Spindle-shaped angioblasts express Po and differentiate 
into endothelial cells in vivo and in vitro
We  further  characterized  GFP+  spindle-shaped  cells  in   
Po-Cre+Flox-CAT-EGFP mice. At first, we expected these 
GFP+ spindle-shaped cells in the avascular area are some neu-
ral or hematopoietic lineage cells. However, multiple marker 
analyses showed that these cells were not astrocytes, ganglion 
cells, photoreceptors, or monocyte/macrophages (Fig. S1,   
B and C). Instead, these spindle cells possessed the features of 
classically termed retinal “angioblasts.” They were positive for 
CD39  and  Nissl,  and  slowly  divided  compared  with  sur-
rounding cells such as astrocytes and ganglion cells (Fig. 2,   
A and B). The results that nonneural crest cells marked by Po 
involve angioblasts and a certain percentage of endothelial 
cells suggested that these cells express Po and have the po-
tential to drive Cre-recombinase in Po-Cre mice. In situ 
hybridization (ISH) showed that Po transcripts (Fig. 2, C 
and D) were abundantly detected in spindle-shaped angio-
blasts in avascular areas, but not in any endothelial cells or 
pericytes. As shown in Fig. 1 (A–J), retinas of Po-Cre+Flox-
CAT-EGFP mice showed GFP expression in endothelial 
cells, pericytes, and retinal angioblasts. Thus, we isolated 
GFP+CD31PDGFR cells from Po-Cre+Flox-CAT-EGFP 
mice by FACS and treated this population as angioblasts. 
Quantitative PCR analysis of FACS-sorted cells showed 
that  mpz,  the  gene  that  encodes  Po,  was  expressed  in 
GFP+CD31PDGFR  cells,  but  far  less  in  GFP+  or 
CD31+PDGFR cells (Fig. 2 E). As there remains a possi-
bility that postnatal GFP+ endothelial cells could originate 
from Po-expressing embryonic endothelial cells, we exam-
ined embryonic Po-Cre expression. The possibility was ne-
gated by the fact that numerous GFP+ cells were only detected 
However, different from other neural crest–specific Cre lines 
(e.g., Wnt1-Cre), Po-Cre marks not only neural crest cells but 
also some nonneural crest cells (e.g., a minor population of 
arterial endothelial cells in adult bone marrow); however, it 
does not mark any endothelial cells during embryogenesis 
(Nagoshi et al., 2008). This observation suggests that Po ex-
pression represents some unknown origin of endothelial cells 
in postnatal tissues.
Recent studies have demonstrated that some neural or 
mesenchymal lineage cells resident in certain tissues have a 
potential to differentiate into endothelial cells in in vitro and 
in vivo, suggesting the existence of tissue-resident vascular 
precursor cells (Beltrami et al., 2003; Planat-Benard et al., 
2004; Wurmser et al., 2004; Grenier et al., 2007). In human 
fetal retinas, morphological analysis has suggested that tissue-
resident retinal “angioblasts” participate in the growth of 
retinal vessels. The retinal angioblasts are characterized by an 
expression profile of CD39+CXCR4+ckit+ or CD45CD31 
and a positivity for Nissl staining (Henking and De Oliveira, 
1967; Ashton, 1970; McLeod et al., 2006). However, these 
studies have investigated neither angioblast endothelial po-
tential nor their actual contribution toward retinal vessels. 
Moreover, retinal angioblasts lack in situ expression of Flk-1, 
the earliest marker for endothelial cell precursors (Millauer 
et al., 1993; Fruttiger, 2002). Therefore, retinal vascularization 
is currently considered to consist of angiogenic growth lack-
ing the participation of precursor cell populations (Gariano 
and Gardner 2005).
The ability to effectively track cell fates throughout devel-
opment depends on the fidelity and permanence of the label-
ing system used. Cell fate mapping of nonmammalian cells 
has been performed using quail-chick chimeras or vital dye 
labeling (Stern and Fraser, 2001; Etchevers et al., 2001). How-
ever, these systems are not effective for determining the long-
term fates of cells in mammals. The use of Cre-loxP–based 
techniques has recently provided the necessary breakthrough 
for mapping progenitor–progeny cell relationships in mice 
(Stern and Fraser, 2001).
In this paper, we used Cre-loxP–based cell fate mapping 
to show that Po+ tissue-resident vascular precursors are re-
cruited into the growing vasculature and comprise a minor 
population of the arterial endothelial cells in adults. We also 
show that Po+ vascular precursors (PVPs) are substantially 
vital not only for retinal vascularization but also for neovascu-
lar formation in ischemic tissues and tumor angiogenesis.
RESULTS
Po-Cre marks endothelial cells and spindle-shaped cells  
in avascular areas
The initial step in our study was to examine the distribution 
of GFP+ cells in Po-Cre+Flox-CAT-EGFP mice undergoing 
postnatal retinal angiogenesis. In a preliminary study, we   
did not detect any abnormality in Po-Cre+Flox-CAT-EGFP 
mice (unpublished data). GFP was detected in endothelial 
cells, desmin+ pericytes/vascular smooth muscle cells (vSMCs) 
and spindle-shaped cells in avascular areas (Fig. 1, A–J). JEM VOL. 208, May 9, 2011 
Article
951
FACS-sorted  angioblasts  into  wild-type  mice,  and  tracked 
their cell fate. 5 d after transplantation, they differentiated into 
endothelial cells, but not pericytes (Fig. 2 L). In FACS analy-
sis, GFP+CD31+ cells, but not GFP+PDGFR+ cells, were 
detected in the recipient retinas (Fig. 2, M and N). Consider-
ing the capacities for endothelial differentiation in vitro and 
in vivo, we designated these GFP+ angioblasts as PVPs. Peri-
vascular spindle-shaped cells marked by Po-Cre, similar to 
PVPs in the retina, existed in nonretinal tissues (Fig. 1, R–T). 
We suspected that these cells possess the characteristics of 
vascular precursor cells. GFP+CD31PDGFR isolated from 
subcutaneous tissues of adult Po-Cre+Flox-CAT-EGFP mice 
were incorporated into the growing vessels in transplanted 
tumors (S-180) and ischemic flaps (Fig. 2, O–Q). This data 
suggests that PVPs were present in subcutaneous tissues.
Recruitment of PVPs is mediated by CXCR4 signaling
A  previous  finding  regarding  the  bone  marrow–derived 
CXCR4+ hemangiocytes (Jin et al., 2006) prompted us to 
study the involvement of CXCL12–CXCR4 signaling in the 
in Sox10+ or p75+ neural crest cells, but not in endothelial 
cells (Fig. S2, A–K), and that GFP+ cells were not detected in 
any pericytes or vSMCs (Fig. S2, L–O). FACS-sorted GFP+ 
angioblasts are negative for CD45 and VE-cadherin, but are 
positive for c-kit, CXCR4, Flk-1, and FGFR1 (Fig. 2 F), 
which are markers for embryonic hemangioblasts or endo-
thelial progenitors (Millauer et al., 1993; Guo et al., 2006).   
In comparison to reported multipotent stem cells, such as very 
small embryonic-like stem cells (Ratajczak et al., 2008) and 
multipotent adult progenitor cells (Jiang et al., 2002), GFP+ 
angioblasts express CD133 but not SSEA-1 (Fig. 2 F). Col-
lectively, the Cre-loxP–based fate-mapping study suggested 
that angioblasts express Po-mRNA and give rise to endothe-
lial cells. So far, the concept of angioblasts has lacked the evi-
dence that they actually differentiate into endothelial cells. 
Therefore, we cultured FACS-sorted GFP+ angioblasts in en-
dothelial culture conditions. After 4 d, they gave rise to CD31+ 
cells (Fig. 2 G) that expressed endothelial cell markers such as 
VE-cadherin, Flk-1, and EphrinB2, but not CD45 (Fig. 2, 
H–K). Next, we performed intraocular transplantation of 
Figure 1.  Po-Cre marks endothelial cells 
and spindle-shaped cells in avascular areas. 
(A–L) Triple IHC for GFP (green), CD31 (blue), 
and desmin (red) in retinas of Po-Cre+Flox-CAT-
EGFP mice at postnatal day (P) 1, 3, 5, 7, and 
90. Representative images from at least three 
independent experiments. GFP+ spindle-shaped 
cells in the avascular area (asterisks), endothe-
lial cells (closed arrowheads), and pericytes/
smooth muscle cells (arrows). A, arterial areas; 
V, venous areas. GFP+ spindle-shaped cells 
associated with filopodia of endothelial tip 
cells, open arrowheads in E–G. (M–P) Qua-
druple IHC for GFP (green), CD31 (blue), ASMA 
(red), and DAPI (white) in retinas of adult Po-
Cre+Flox-CAT-EGFP mice. O and P are images 
from a cross section. Representative images 
from three independent experiments. GFP+ 
lumen-forming endothelial cells (arrowheads) 
and smooth muscle cells (arrows).  
(Q) FACS analysis of dissociated retinal cells 
from adult Po-Cre+Flox-CAT-EGFP mice. 4.88 ± 
1.84% (n = 5) of CD31+ cells were GFP+.  
(R–T) Triple IHC for GFP (green), CD31 (blue), 
and ASMA (red) in various tissues from adult 
Po-Cre+Flox-CAT-EGFP mice. GFP+ endothelial 
cells (closed arrowheads), pericytes/vSMCs 
(arrows), and spindle-shaped cells in the avas-
cular area (open arrowheads). Representative 
images from three independent experiments. 
(U–X) Triple IHC for GFP (green), CD31 (blue), 
and desmin (red) at P4 in Wnt1-Cre/Flox-CAT-
EGFP mice (U and V) or Ht-PA-Cre/Flox-CAT-
EGFP mice (W and X). Representative images 
from seven independent experiments. GFP+ 
pericytes/smooth muscle cells are indicated by 
arrows. Bars: (A–D, K, and L) 100 µm; (E–J and 
R–X) 50 µm; (M–P) 10 µm.952 Tissue-resident vascular precursors | Kubota et al.
expressed  in  vascularized  areas  rather  than  avascular  areas   
(Fig. 3, A–C). The major CXCL12-expressing cells were as-
trocytes, and CXCL12 was not expressed by microglia or 
recruitment of PVPs. We examined the expression pattern of 
CXCL12  in  the  developing  retina  using  CXCL12+/EGFP 
knock-in  mice.  Surprisingly,  CXCL12  was  predominantly 
Figure 2.  Spindle-shaped angioblasts express Po and differentiate into endothelial cells in vivo and in vitro. (A and B) IHC of retinas from Po-Cre+Flox-
CAT-EGFP mice at P4 stained with indicated antibodies. Representative images from three independent experiments. GFP+ spindle-shaped cells (open arrowheads). 
(C and D) ISH for Po (purple) combined with isolectin staining (green) at P3. Representative images from three independent experiments. Spindle-shaped cells in 
the avascular area (open arrowheads). Endothelial cells (closed arrowheads). (E) Quantitative PCR analysis of mpz expression in FACS-sorted retinal cells at P3  
(n = 6). (F) FACS analysis of dissociated retinal cells from Po-Cre+Flox-CAT-EGFP mice at P3. Representative plots from at least three independent experiments. 
Black histograms, isotype control staining. (G–K) GFP+CD31PDGFR cells from Po-Cre+Flox-CAT-EGFP mice at P3 stained with indicated antibodies after 4 d  
of culture. Representative images from at least three independent experiments. (L) FACS-sorted GFP+CD31PDGFR cells from P3 Po-Cre+Flox-CAT-EGFP mice 
were intraocularly transplanted into recipient mice at P1, and sacrificed at P6. GFP+ endothelial cells, closed arrowheads; pericytes, arrows. Representative  
images from 10 independent experiments. (M and N) FACS analysis of dissociated retinal cells from mice intraocularly transplanted with FACS-sorted 
GFP+CD31PDGFR cells at P1. Representative plots from three independent experiments. (O) FACS plots of dissociated cells from subcutaneous tissues of adult 
Po-Cre+Flox-CAT-EGFP mice. Representative plots from three independent experiments. (P and Q) GFP+CD31PDGFR cells were transplanted into the S-180 
tumors and ischemic flaps. Representative images from three independent experiments. GFP+ endothelial cells, closed arrowheads. Bars, 50 µm. **, P < 0.01.JEM VOL. 208, May 9, 2011 
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pericytes (Fig. 3, M–O). Moreover, CXCL12 expression was 
detected in arterial endothelial cells and tip cells, but not venous 
endothelial  cells  (Fig.  3,  D–L).  In  in  vitro  chemotaxis  assay, 
CXCL12 increased chemotaxis of FACS-sorted PVPs in a dose-
dependent manner, and the chemotactic effect was abrogated 
by  pretreatment  of  cells  with  CXCR4-specific  antagonist 
(TN14003;  Fig.  3  P).  Pretreatment  of  isolated  PVPs  with 
TN14003  significantly  decreases  incorporation  of  trans-
planted PVPs into recipient vasculature (Fig. 3 Q). Systemic 
treatment of mice with TN14003 led to formation of a sparse 
vascular network (Fig. 3, R and S). Yet it is unclear whether 
this vasoinhibitory effect was owed to PVPs or mature endo-
thelial cells. These results suggest that the recruitment of PVPs 
is mediated through CXCR4 signaling.
Recruitment of PVPs is enhanced during vascular expansion 
induced by Notch inhibition
Dll4-Notch1 signaling is known to regulate vascular pattern-
ing by inducing endothelial tip cell conversion into stalk cells 
(Hellström et al., 2007; Suchting et al., 2007). We used a   
-secretase inhibitor, DAPT, which is widely used for analyz-
ing vascular changes induced by Notch inhibition (Hellström   
et al., 2007; Tammela et al., 2008). When Po-Cre+Flox-CAT-
EGFP mice were treated with DAPT, GFP+ endothelial tip 
cells were increased and GFP+ stalk cells were decreased at   
3–6 h after administration (Fig. 4, A and B). The GFP+ tip/stalk 
ratio peaked at 3–6 h after DAPT injection. At 12–48 h after 
administration, both GFP+ stalk cells and tip cells had in-
creased (Fig. 4, C-F). DAPT significantly increased not only 
the number of GFP+ endothelial cells but also their Flk-1 ex-
pression (Fig. 4 H). Endothelial CXCL12 expression is up-
regulated 12 h after DAPT administration (Fig. 4 I), which 
may account for a delayed increase in the recruitment of PVPs 
into the vasculature. When mice were subjected to continu-
ous DAPT treatment, GFP+ endothelial cells were dramati-
cally increased in number, but remained in the capillary 
plexus, and their incorporation into arteries was inhibited 
(Fig. 4, J, K, and N). Inhibition of Dll4/Notch signaling by the 
application of Dll4-neutralizing antibodies increased GFP+ 
endothelial cells (Fig. S3, A–C) in a manner similar to DAPT 
treatment. First, we suspected that anti-Dll4 antibodies directly 
affect the behavior of PVPs. However, Dll4 and Notch1 were 
expressed only in mature endothelial cells, and not in PVPs 
(Fig. 4 P). Moreover, anti-Dll4 antibodies did bind to endothelial 
cells, but not to PVPs (Fig. S3, D–I), suggesting that Dll4 inhi-
bition does not affect PVPs directly. To assess the effect of 
enhanced Notch signaling, we used a Jag1 peptide, which is 
Figure 3.  Recruitment of PVPs is mediated by CXCR4 signaling.  
(A–O) IHC in the retina of CXCL12+/EGFP mice at P4. Representative images 
from three independent experiments. Vascularized area is represented by 
asterisks. Tip cells are indicated by arrowheads in D–F. Arterial endothelial 
cells are indicated by arrowheads in J–L. Astrocytes are indicated by  
arrows. Venous endothelial cells are indicated by open arrowheads in G–I. 
Microglia are indicated by double arrows. (P) In vitro chemotaxis assay of 
isolated PVPs (GFP+CD31PDGFR; n = 4). CXCL12 was added at indicated 
doses to the lower chamber. Preincubation with TN14003 (CXCR4-specific 
antagonist) were performed when indicated. (Q) Quantification of GFP+ 
endothelial cells per field (n = 10) in recipient retinas (P5) intraocularly 
transplanted with Vehicle or TN14003-treated GFP+CD31PDGFR cells 
at P3. (R and S) Retinas from Po-Cre+Flox-CAT-EGFP mice (P4) continu-
ously treated with vehicle or TN14003 (P1-4) were stained with anti-
CD31. Representative images from three independent experiments.  
Bars, 100 µm. *, P < 0.05; **, P < 0.01.
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Po-conditional Flk-1 knockout mice show defective vascular 
branching and arterial patterning
VEGF/Flk-1 signaling is essential for endothelial survival/ 
proliferation, tip cell formation, and arterial patterning (Shalaby 
et al., 1995; Lawson et al., 2002; Gerhardt et al., 2003; Jakobsson 
et al., 2010). To characterize the physiological roles of PVP- 
derived endothelial cells during vascular patterning, we gener-
ated mice with a Po-specific conditional knockout of Flk1 
widely used for analyzing vascular changes induced by Notch 
gain-of-function (Hellström et al., 2007). Continuous adminis-
tration of a Jag1 peptide significantly decreased the number of 
GFP+ endothelial cells (Fig. 4, L, M, and O). Collectively, recruit-
ment of PVPs was enhanced during vascular expansion induced 
by Notch inhibition. However, the effect of Notch inhibition 
on PVPs is likely to be an indirect one, and partly mediated 
by the up-regulation of CXCL12 in endothelial cells.
Figure 4.  Recruitment of PVPs is enhanced during vascular expansion induced by Notch inhibition. (A–D) IHC for GFP (green) and CD31 (blue) after 
subcutaneous injection of DAPT at P4. GFP+ tip cells are indicated by arrowheads. Stalk cells are indicated by the area within the dashed line. Representative 
images from six independent experiments. (E) An image for discriminating GFP+ tip cells and stalk cells. (F) Quantification of GFP+ tip cells or GFP+ tip/stalk cell 
ratios (n = 6). (G and H) Quantitative flk-1 expression analysis in FACS-sorted GFP+CD31+ cells gated on PDGFR cells in the retinas of Po-Cre+Flox-CAT-
EGFP mice at P4 12 h after vehicle or DAPT administration (n = 7). (I) Quantitative PCR analysis of cxcl12 in FACS-sorted CD31+ cells 12 h after vehicle or 
DAPT treatment (n = 7). (J and K) P4 retinas of Po-Cre+Flox-CAT-EGFP mice after continuous vehicle or DAPT treatment (P1–4). Insets indicate arterial areas. 
Representative images from eight independent experiments. (L and M) P5 retinas of Po-Cre+Flox-CAT-EGFP mice after pulse treatment from P1 to P5 with 
scramble Jag1 peptides (L) or Jag1 peptides (M). Representative images from eight independent experiments. (N and O) Quantification of GFP+ endothelial 
cells (n = 8). (P) IHC of retinas from Po-Cre+Flox-CAT-EGFP mice at P4 stained with indicated antibodies. Representative images from three independent ex-
periments. Closed arrowheads, mature endothelial cells; open arrowheads, PVPs. Bars: (A–D, J–M, and P) 100 µm; (E) 20 µm. *, P < 0.05.JEM VOL. 208, May 9, 2011 
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in Flk-1+/EGFP knock-in mice (Ema et al., 2006), was expressed 
in endothelial cells, Muller cells, and photoreceptors in the 
outer nuclear layer, but not in spindle-shaped angioblasts   
(Fig. S4, A and C). The Flk-1 expression in Flk-1Po-CKO mice 
showed reduction in endothelial cells but not in Muller cells 
(Fig. S4, B and D). To rule out the effects of Flk-1 inactivation 
in other cells, such as neural crest cells, we thoroughly examined 
Flk-1 expression. We could not detect Flk-1 expression in neural 
crest cells, neurons, Schwann cells, vSMCs, or pericytes through-
out the body except for in the central nervous system (Fig. S5). 
However, as even undetectable levels of Flk-1 expression in neu-
ral crest cells may be vital, we generated Wnt1-specific Flk-1 
knockout (Flk-1Wnt1-CKO) mice (Wnt1-Cre+Flk-1Flox/Flox). Wnt1-
Cre is expressed in neural crest cells (Danielian et al., 1998; 
Nagoshi et al., 2008) and all pericytes/vSMCs in the retinas of 
mice at P4. Flk-1Wnt1-CKO mice develop normally and do not 
exhibit any vascular defects in their postnatal retina (Fig. 5,   
P–U). Therefore, vascular defects in Flk-1Po-CKO mice are likely 
caused  by  impairment  in  PVPs  and 
PVP-derived  endothelial  cells  rather 
than defects in neural crest cells or peri-
cytes/vSMCs. Flk-1Po-CKO mice showed 
significantly decreased endothelial pro-
liferation, increased endothelial apop-
tosis, and increased empty basement 
membrane sleeves that are positive for 
collagen  IV,  but  lacking  endothelial 
markers,  such  as  isolectinB4,  which 
consistently highlight vessel regression 
(Phng et al., 2009; Fig. S6).
(Po-Cre/Flox-flk1: termed “Flk-1Po-CKO mice”). In a preliminary 
study, Po-Cre-Flk-1Flox/lacZ mice did not show significant defects 
compared with Po-CreFlk-1Flox/+ or Po-Cre+Flk-1Flox/+ litter-
mates (unpublished data). The retinas of Flk-1Po-CKO mice at P4 
showed significantly decreased vascular branching, although the 
decrease in tip cell number was only moderate (Fig. 5, A, B, 
and K–M). Arterial patterning was incomplete and blood flow 
was poor in the retinas of Flk-1Po-CKO mice (Fig. 5, C, D, and N).   
Although recruitment of desmin+ pericytes was normal, expres-
sion of arterial smooth muscle actin (ASMA) was reduced in 
Flk-1Po-CKO mice (Fig. 5, E–H, and O). The observation of in-
creased numbers of PVP-derived capillary endothelial cells after 
Notch inhibition (Fig. 4, J and K) prompted us to examine vas-
cular abnormalities of Flk-1Po-CKO mice after DAPT treatment. 
When Flk-1Po-CKO mice were continuously administered DAPT, 
they exhibited severe irregularities in vasculature patterning 
(Fig. 5, I and J). In agreement with a previous work (Jakobsson 
et al., 2010), Flk-1 expression, determined by GFP expression 
Figure 5.  Po-conditional Flk-1 knockout 
mice show branching defects and insuf-
ficient arterial patterning. (A–D) Perfusion 
staining of blood flow (green) combined with 
CD31 staining (white in A and B; blue in  
C and D). Representative images from eight 
independent experiments. Red dots, tip cells. 
Yellow dots, branching points. Arteries, A. 
Veins, V. (E–H) Triple IHC for ASMA (green), 
desmin (red), and CD31 (blue). Smooth muscle 
cells (open arrowheads in H). Representative 
images from eight independent experiments.  
(I and J) P4 retinas after continuous DAPT 
treatment (P1–4). Asterisks indicate severely 
obliterated areas. Representative images from 
three independent experiments. (K–O) Quanti-
fication of relative flk-1 expression (n = 5), tip 
cells (n = 8), branching points (n = 8), relative 
FITC intensity (n = 8), and relative ASMA in-
tensity (n = 8). (P–S) Triple IHC for ASMA 
(green), Isolectin (white in P and Q; blue in  
R and S), and desmin (red) at P4. Representa-
tive images from six independent experi-
ments. (T and U) Quantification (n = 6). Bars: 
(A–D, I, J, and P–S) 100 µm; (E–H) 50 µm.  
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was  observed  in  Flk-1Po-CKO  mice  compared  with  control 
mice (Fig. 6, G, H, K, and L). Collectively, PVP-derived endo-
thelial cells contribute to the neovascular formation in isch-
emic tissues and tumor angiogenesis.
DISCUSSION
In this study, we identified tissue-resident vascular precursors 
marked by Po. During physiological development, PVPs   
were recruited into the growing vasculature, and comprised a   
minor population of the arterial endothelial cells in adults. 
CXCL12–CXCR4 signaling mediates recruitment of PVPs 
into the vessels. Tip/stalk transition of PVP-derived endothe-
lial cells is regulated by Dll4/Notch1 signaling.
A previous study clearly showed that retinal angioblasts 
lack detectable Flk-1 expression in ISH (Fruttiger, 2002). In 
contrast, our FACS analysis revealed weak Flk-1 expression in 
PVPs, although we failed to detect Flk-1 expressions using 
immunohistochemistry. This controversy is likely caused by 
the difference in the detection method used. FACS analysis 
may be more sensitive than ISH and immunohistochemistry 
(IHC) in detecting Flk-1 expression. In this regard, vascular 
defects in Flk-1Po-CKO mice are likely caused by decreased en-
dothelial proliferation, increased endo-
thelial apoptosis, and excessive vascular 
regression in stalk cells, rather than de-
fective tip cells (i.e., defective differ-
entiation of PVPs). Considering that 
vascular regression is highly dependent 
on the VEGF–Notch–Nrarp pathway 
PVPs contribute to neovascular formation into ischemic 
tissues and tumor angiogenesis
Reportedly,  rapidly  expanding  vasculature  at  the  capillary 
level seen during Notch inhibition mimics the pathologi-
cal state of the vasculature in disease states such as cancer 
(Noguera-Troise et al., 2006; Ridgway et al., 2006). The in-
creased functional contribution of PVP-derived endothelial 
cells after Notch inhibition as seen in retinal vessels (Fig. 4 K 
and Fig. 5, I and J) prompted us to examine their roles in   
tumor angiogenesis. To examine the role of PVPs in a cancer 
model, murine tumor cells (S-180) were transplanted subcu-
taneously into the bilateral axillae of Po-Cre+Flox-CAT-EGFP 
mice. GFP+ endothelial cells were more abundant in the   
tumor vasculature than in surrounding subcutaneous tissues 
(Fig. 6, A and B). Flk-1Po-CKO mice transplanted with S-180 
cells showed reduced tumor growth and less tumor angiogen-
esis than control mice transplanted with S-180 cells (Fig. 6, E, 
F, I, J, and M). To induce ischemic areas in adult tissues outside 
the retina, we used the ischemic skin flap model. GFP+ endo-
thelial cells in Po-Cre+Flox-CAT-EGFP mice were abundant 
in collateral vessels 7 d after flap elevation (Fig. 6, C and D). 
Wider necrotic areas and decreased collateral vessel formation 
Figure 6.  PVPs functionally contribute to 
tumor angiogenesis and neovascular for-
mation into ischemic flaps. (A–D) Tumors or 
surrounding tissues 10 d after transplantation 
of S-180 cells, or ischemic flap tissues 7 d 
after flap elevation in adult Po-Cre+Flox-CAT-
EGFP mice. Arrowheads, GFP+ endothelial 
cells. Representative images from at least 
three independent experiments. (E–H) Macro-
scopic view of tumors 10 d after transplanta-
tion of S-180 cells, or ischemic flap tissues  
7 d after flap elevation in adult control or  
Flk-1Po-CKO mice. Representative images from 
12 independent experiments. Tumors in E are 
indicated by arrowheads. Necrotic areas in G 
are indicated by dotted line areas. The asterisk 
in H indicates collateral vessels. (I–L) Repre-
sentative sections of tumors 10 d after trans-
plantation of S-180 cells, or ischemic flap 
tissues 7 d after flap elevation in adult control 
or Flk-1Po-CKO mice. Representative images 
from 12 independent experiments.  
(M and N) Quantification of tumor volume, 
necrotic area in the ischemic flaps, or percent 
capillary density (n = 12). Bars: (A–D) 500 µm; 
(I–L) 100 µm. *, P < 0.05; **, P < 0.01 (com-
pared with control).JEM VOL. 208, May 9, 2011 
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such  as  tumor  angiogenesis.  Future  studies  may  address 
whether PVP-targeted therapy is a promising strategy for 
treatment of human neovascular such as cancer.
MATERIALS AND METHODS
Mice. Animal care was performed in accordance with the Guidelines of 
Keio University for Animal and Recombinant DNA experiments. Transgenic 
mice expressing Cre recombinase under the control of the Po promoter   
(Po-Cre), the Wnt1 promoter/enhancer (Wnt1-Cre), and the Ht-PA promoter 
(Ht-PA-Cre;  Pietri  et  al.,  2003)  were  mated  with  Flox-CAT-EGFP  mice 
(Kawamoto et al., 2000) to obtain Po-Cre+Flox-CAT-EGFP, Wnt1-Cre+Flox-
CAT-EGFP, and Ht-PA-Cre+Flox-CAT-EGFP double-transgenic mice. To 
obtain Po-conditional knockout mice for Flk-1, we initially generated Po-
Cre+Flk-1+/lacZ double-transgenic mice by mating Po-Cre mice with Flk-1+/lacZ 
mice (Shalaby et al., 1995). The Po-Cre+Flk-1+/lacZ mice were then mated 
with Flk-1Flox/Flox mice (Albuquerque et al., 2009). As littermate controls for the 
conditional knockout mice (Po-Cre+Flk-1Flox/lacZ), we used Po-CreFlk-1Flox/lacZ 
mice throughout this study.
Preparation of whole-mount samples. Enucleated eyes or other tissues 
were fixed for 20 min in 4% PFA in PBS, and then dissected. Retinal cups or 
other tissues were post-fixed and stored in methanol at 20°C.
Whole-mount immunostaining and ISH. IHC of whole-mount sam-
ples was performed as previously described (Kubota et al., 2008). For whole-
mount ISH, retinas were digested with proteinase K and hybridized with 
DIG-labeled antisense RNA probes. When ISH was combined with IHC, 
IHC was performed after ISH procedures were completed as previously de-
scribed (Fruttiger, 2002). For the BrdU incorporation assay, 100 µg per gram 
of body weight of BrdU (BD) dissolved in sterile PBS was injected intraperi-
toneally 2 h before sacrifice. Isolated retinas were stained using a BrdU IHC 
system (EMD).
Subcutaneous  injection  of  pharmacological  reagents.  100  mg/kg 
DAPT (EMD) dissolved in DMSO was administered subcutaneously (injec-
tion volume 10 µl/g body weight). Control mice were injected with vehicle 
only. Jag1 peptide (CDDYYYGFGCNKFCRPR) or a scrambled peptide 
(RCGPDCFDNYGRYKYCF; Hellström et al., 2007) was synthesized by 
Sigma-Aldrich, dissolved at 10 mg/ml in DMSO, and injected (25 µl/injection) 
subcutaneously.  Hamster  Dll4-neutralizing  antibodies  dissolved  in  sterile 
PBS at 2.5 mg/ml were injected subcutaneously (25 µl/injection). Control 
mice were injected with the same amount of nonspecific hamster IgG. 
TN14003 was dissolved in PBS (0.5 mg/ml) and administered subcutane-
ously (injection volume 20 µl/g body weight per day).
Antibodies. The primary monoclonal antibodies used were as follows: ham-
ster anti-CD31 (2H8; Millipore), rat anti-CD31 (MEC13.3; BD), PDGFR 
(APA5; eBioscience), -smooth muscle actin (1A4; FITC or Cy3-conjugated; 
Sigma-Aldrich), GFAP (G-A-5; Cy3-conjugated; Sigma-Aldrich), neurofila-
ment (2H3; Developmental Studies Hybridoma Bank), Pax-6 (Developmental 
Studies Hybridoma Bank), VE-cadherin (11D4.1; BD), Mac-1 (M1/70; BD), 
CD45 (BD), F4/80 (CI:A3-1; Serotec), PDGFR (APB5; eBioscience), des-
min  (DAKO),  and  Dll4  (provided  by  Hideo Yagita,  Juntendo  University, 
Chiba, Japan). The primary polyclonal antibodies used were as follows: anti-
GFP  (Alexa  Fluor  488  conjugated;  Invitrogen),  Pax-2  (Covance),  Flk-1 
(Sigma-Aldrich), PDGFR (Santa Cruz Biotechnology, Inc.), CD39 (Santa 
Cruz Biotechnology, Inc.), EphrinB2 (Santa Cruz Biotechnology, Inc.), c-kit 
(R&D Systems), CXCR4 (eBioscience), Collagen IV (Cosmo Bio), cleaved 
Notch1 (Cell Signaling Technology), Sox10 (R&D Systems), p75 (EMD), 
and MBP (Aves Laboratories). Secondary antibodies used were as follows:   
Alexa 488 fluorescence–conjugated IgGs (Invitrogen) or Cy3/Cy5-conjugated 
IgGs (Jackson ImmunoResearch Laboratories). For nuclear staining, speci-
mens were treated with TOTO3 (Invitrogen) or DAPI (Invitrogen). In some 
experiments, blood vessels and monocyte-lineage cells were simultaneously 
(Phng et al., 2009), and that Flk-1/ embryonic stem cells 
can differentiate into endothelial cells (Schuh et al., 1999), 
vascular defects in Flk-1Po-CKO mice are likely caused by im-
pairment in survival and expansion of PVP-derived stalk cells 
rather than endothelial differentiation of PVPs.
In chick embryos, the dorsal aorta originates from not 
only the splanchnic mesoderm, but also the somitic meso-
derm, which contains tissue-resident mesodermal cells that 
are distributed before vascular growth (Sato et al., 2008). PVP 
recruitment in the postnatal retina is similar to the model 
proposed in this study. Regarding the origin of PVPs, our data 
and previous studies (Etchevers et al., 2001; Gage et al., 2005) 
indicate that they are likely derived from the mesoderm but 
not neural crest. Recently, a differentiation system of human 
embryonic stem cells (hESCs) identified a common endothe-
lial and mesenchymal cell precursor within a mesodermal 
subset, called “mesenchymoangioblast” (Vodyanik et al., 2010). 
Interestingly, this cell population has a potential to differenti-
ate into endothelial cells, as well as mesenchymal stem cells 
with chondro-, osteo-, and adipogenic differentiation poten-
tials. Po-Cre+ cells in the bone marrow have the potential to 
give rise to mesenchymal stem cells in an in vitro culture 
(Morikawa et al., 2009). Our identified PVPs may represent   
a cell population similar to “mesenchymoangioblast” in the 
hESC differentiation system (Vodyanik et al., 2010). Interest-
ingly, glioblastoma stemlike cells differentiate into endothelial 
cells in the tumor vasculature, suggesting plasticity of neural 
and endothelial lineages, especially during aggressive vascular 
expansion (Wang et al., 2010; Ricci-Vitiani et al., 2010).
In terms of postnatal vasculogenesis by bone marrow– 
derived cells, the highly variable extent of the contribution of 
EPCs may reflect differences in genetic background or the 
nature of the angiogenic stimulus (Asahara et al., 1997; Gao   
et al., 2008; Purhonen et al., 2008). Previously, we found there 
are no Po+ cells in circulation, at least after birth (Nagoshi   
et al., 2008), suggesting that PVPs are not a kind of so-called 
EPC, but tissue-resident endothelial precursor cells.
It still remains unclear whether Po is simply a marker of 
PVPs or also plays a role in the genesis or differentiation of 
PVPs. Po/ mice develop normally, at least until birth (Giese 
et al., 1992), and do not show apparent vascular defects in tis-
sue sections from various adult organs (unpublished data). 
However, Po/ mice are smaller in size than wild-type or 
heterozygous littermates several weeks after birth, suggesting 
that some vascular defects may well exist. If we assume that 
PVPs are defective in Po/ mice, the fact that no major vas-
cular defects occur in Po/ mice is consistent with our con-
clusion that postnatally growing vessels are primarily formed 
through angiogenesis from preexisting vessels, and that a   
minor population of the arterial endothelia is derived from 
Po+ tissue-resident precursor cells.
In summary, we identified postnatal vascular precursors 
marked  by  Po,  which  exhibit  a  CD45CD31VEcad   
c-kit+CXCR4+ surface phenotype. PVPs are recruited into 
vasculature during physiological development and more ac-
tively into expanding capillaries during hypervascular conditions, 958 Tissue-resident vascular precursors | Kubota et al.
retinal cells section. Cells were resuspended in EBM-2 containing 0.2% FBS, 
added to the upper wells (2 × 104 cells/well), and incubated for 4 h. Cells 
were then fixed by 100% methanol, washed, and stained with hematoxylin 
solution. In some experiments, PVPs were preincubated with the CXCR4 
antagonist, TN14003 (4 µg/ml), or control medium for 30 min in EBM-2 
containing 0.2% FBS. The number of cells attached to the lower surface of 
the membranes was counted microscopically. Cells were counted in 10 ran-
domly chosen high-power fields on the membrane, and an average number 
was obtained. Experiments were repeated 4 times.
Tumor transplantation model. Sarcoma 180 (S-180) murine transplant-
able tumor cells (provided by T. Shindo, Shinshu University Graduate School 
of Medicine, Matsumoto, Nagano, Japan) that had been cultured in the abdo-
men were isolated from the ascites. After removal of red blood cells, tumor 
cells were transplanted by subcutaneous injection into the bilateral axillae of 
15-wk-old male mice at a dose of 2 × 106 cells in 0.2 ml per mouse. Tumors 
were removed for analysis 10 d after transplantation.
Ischemic flap model. Dorsal flaps (1 × 5 cm) were introduced onto the 
backs of 15-wk-old male mice in a modification of the previous study 
(Ceradini et al., 2004). The flaps were raised with the base at the tail end, 
including intimately attached panniculus carnosus. The flaps were then 
sutured back to the donor bed using 4–0 Nylon. Ischemic tissues in the 
distal end of the flaps were harvested for analysis 7 d after flap elevation. 
Necrotic areas were quantified using ImageJ Software (National Institutes 
of Health).
Confocal microscopy. Fluorescent images were obtained using a confo-
cal laser scanning microscope (FV1000; Olympus). Quantification of cells 
or substances of interest was done on eight 200 × 200 µm fields of view 
per sample in scanned images, and numbers obtained from each of the 
eight fields were averaged. Scion image software (Scion Corporation)   
was used for quantification of fluorescence intensity or capillary density in 
confocal images.
Statistical analysis. All results are expressed as mean ± SD. The comparison 
between the averaged variables of two groups was evaluated using the two-
tailed Student’s t test. P < 0.05 was considered statistically significant.
Online  supplemental  material. Fig. S1 shows the IHC data showing 
that Po-Cre+ spindle-shaped cells are negative for pericytic, neuronal, and 
hematopoietic markers. Fig. S2 shows the IHC data showing that Po-Cre 
does not mark embryonic endothelial cells. Fig. S3 shows the data showing 
that Dll4 neutralization enhance the recruitment of PVPs. Fig. S4 shows the 
IHC data showing that Flk-1 expression in Flk-1Po-CKO mice show reduc-
tion in endothelial cells but not in Muller cells and photoreceptors. Fig. S5 
shows the IHC data showing that Flk-1 is expressed in endothelial cells, 
but not neural crest cells, neurons, Schwann cells, or pericytes/vSMCs.   
Fig. S6 shows the IHC data showing that Flk-1Po-CKO mice show decreased 
endothelial proliferation, increased endothelial apoptosis, and increased vessel 
regression. Online supplemental material is available at http://www.jem.org/ 
cgi/content/full/jem.20102187/DC1.
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visualized using biotinylated isolectin B4 (Sigma-Aldrich), followed by fluo-
rescent  streptavidin  conjugates  (Invitrogen),  and  vascular  precursors  were   
visualized by NeuroTrace Fluorescent Nissl Stains (Invitrogen). For visualiza-
tion of blood flow, FITC-conjugated Dextran (Sigma-Aldrich) was injected 
into the left cardiac ventricle and allowed to circulate for 2 min. For FACS 
analysis, fluorophore- or biotin- conjugated primary antibodies against 
CD31 (MEC13.3), CXCR4 (BD), c-Kit (2B8; BD), VE-cadherin (BV13; 
eBioscience), Tie2 (TEK4; eBioscience), PDGFR (Santa Cruz Biotech-
nology,  Inc.),  Flk-1  (Avas121;  BD),  FGFR1  (QED  Bioscience  Inc.), 
CD133  (13A4;  eBioscience),  SSEA1  (MC-480;  eBioscience),  PDGFR 
(APA5; eBioscience), or CD45 (30F11; BD) were used. Biotin-conjugated 
antibodies  were  visualized  by  incubation  with  fluorophore-conjugated 
streptavidin (BD).
Flow cytometric analysis of retinal cells. Retinas of Po-Cre+Flox-CAT-
EGFP were incubated for 30 min at 37°C in DMEM containing 1% colla-
genase D (from Clostridium histolyticum) before cells were dissociated by 
gentle trituration. Dissociated single cells were preincubated with Fc block 
(BD) to avoid nonspecific binding of antibodies, and then incubated with in-
tended antibodies. Stained samples were analyzed by SORP FACSAria (BD) 
with FlowJo software (Tree Star) or CellQuest software (BD). Debris and 
dead cells were excluded by forward and side scatter and a negative gate for 
propidium iodide staining. Percentages of cell doublets/aggregates were checked 
by FSC-A versus FSC-W, and SSC-A versus SSC-W plots. In all FACS stud-
ies, we routinely included unstained control samples and compensation tubes 
for FITC, PE, APC, and APC-Cy7. Using these negative and positive control 
tubes, we set fluorescence voltages and the compensation matrix according to 
the instructions of the manufacturer. We applied these setting parameters to 
all the samples that were analyzed.
Quantitative RT-PCR analysis. Total RNA was prepared from FACS-
sorted cells or retinal tissues, and reverse transcription was performed using 
Superscript II (Invitrogen). Quantitative PCR assays were performed on an 
ABI 7500 Fast Real-Time PCR System using TaqMan Fast Universal PCR 
master mixture (Applied Biosystems) and TaqMan Gene Expression Assay 
Mix  of  mpz  (Mm00485139_m1),  cxcl12  (Mm00445552_m1),  or  flk-1 
(Mm00440099_m1). A mouse -actin (Mm00607939_s1) assay mix served as 
an endogenous control. Data were analyzed by 7500 Fast System SDS Soft-
ware 1.3.1. Each experiment was performed with four replicates from each 
sample, and the results were averaged.
Cell culture. GFP+CD31PDGFR cells were isolated from the retinas of 
Po-Cre+Flox-CAT-EGFP  mice  by  FACS  as  described  above.  Cells  were 
washed and resuspended in EGM-II (Cambrex) containing 5% FBS, and then 
plated on Fibronectin-coated culture slides (BD) at a density of 2 × 104 
cells/cm2. After 4 d of culture, cells were fixed with 4% paraformaldehyde in 
PBS for 30 min and subjected to IHC.
Intraocular transplantation. Intraocular transplantation of FACS-sorted 
cells was performed using 33-gauge needles, as described previously (Kubota 
et al., 2008). In one eye of each wild-type animal at P1, 2,000 cells sus-
pended in 0.2 µl of DMEM containing 2% FBS were gently injected just be-
tween the iris and retina under a microscope. Recipient mice were sacrificed 
at P6. In some experiments, PVPs isolated from P3 retinas were preincubated 
with the CXCR4 antagonist, TN14003 (4 µg/ml; Tamamura et al., 2001) or 
vehicle for 60 min in DMEM containing 2% FBS, and transplanted into the 
retinas of P3 mice. Recipient mice were sacrificed at P5.
Chemotaxis assay. The chemotaxis assay was performed using Transwell 
membrane filters (8.0-µm pore; Corning). Both the upper and lower sur-
faces of the membranes were coated with 0.1% gelatin. 600 µl of EBM-2 
containing 0.2% FBS, with or without indicated concentrations of CXCL12 
(R&D Systems), was added to the lower wells of 24-well plates. PVPs 
(GFP+CD31PDGFR) were isolated from the retinas of Po-Cre+Flox-
CAT-EGFP mice by FACS as described in the Flow cytometric analysis of JEM VOL. 208, May 9, 2011 
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